Bank of New York Mellon’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-17
| Closed | -$24K | – | 4552 |
|
|
2022
Q2 | $24K | Sell |
17
-39
| -70% | -$55.1K | ﹤0.01% | 4472 |
|
|
2022
Q1 | $117K | Hold |
56
| – | – | ﹤0.01% | 4375 |
|
|
2021
Q4 | $274K | Buy |
56
+1
| +2% | +$4.89K | ﹤0.01% | 4135 |
|
|
2021
Q3 | $345K | Buy |
55
+4
| +8% | +$25.1K | ﹤0.01% | 3977 |
|
|
2021
Q2 | $480K | Buy |
51
+6
| +13% | +$56.5K | ﹤0.01% | 3789 |
|
|
2021
Q1 | $389K | Buy |
45
+5
| +13% | +$43.2K | ﹤0.01% | 3813 |
|
|
2020
Q4 | $301K | Buy |
40
+13
| +48% | +$97.8K | ﹤0.01% | 3828 |
|
|
2020
Q3 | $180K | Buy |
27
+1
| +4% | +$6.67K | ﹤0.01% | 3867 |
|
|
2020
Q2 | $196K | Buy |
26
+6
| +30% | +$45.2K | ﹤0.01% | 3800 |
|
|
2020
Q1 | $144K | Buy |
20
+1
| +5% | +$7.2K | ﹤0.01% | 3809 |
|
|
2019
Q4 | $301K | Hold |
19
| – | – | ﹤0.01% | 3798 |
|
|
2019
Q3 | $184K | Sell |
19
-1
| -5% | -$9.68K | ﹤0.01% | 3914 |
|
|
2019
Q2 | $312K | Buy |
20
+15
| +300% | +$234K | ﹤0.01% | 3790 |
|
|
2019
Q1 | $85K | Sell |
5
-1
| -17% | -$17K | ﹤0.01% | 4020 |
|
|
2018
Q4 | $53K | Buy |
6
+1
| +20% | +$8.83K | ﹤0.01% | 4046 |
|
|
2018
Q3 | $68K | Hold |
5
| – | – | ﹤0.01% | 4080 |
|
|
2018
Q2 | $63K | Hold |
5
| – | – | ﹤0.01% | 4052 |
|
|
2018
Q1 | $64K | Buy |
+5
| New | +$64K | ﹤0.01% | 4119 |
|
|
2017
Q3 | – | Sell |
-9
| Closed | -$14K | – | 4267 |
|
|
2017
Q2 | $14K | Buy |
+9
| New | +$14K | ﹤0.01% | 4250 |
|